Helmet continuous positive airway pressure versus high-flow nasal cannula in COVID-19: a pragmatic randomised clinical trial (COVID HELMET)

BACKGROUND: Patients with COVID-19 and hypoxaemia despite conventional low-flow oxygen therapy are often treated with high-flow nasal cannula (HFNC) in line with international guidelines. Oxygen delivery by helmet continuous positive airway pressure (CPAP) is a feasible option that enables a higher...

Descripción completa

Detalles Bibliográficos
Autores principales: Tverring, Jonas, Åkesson, Anna, Nielsen, Niklas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711053/
https://www.ncbi.nlm.nih.gov/pubmed/33272319
http://dx.doi.org/10.1186/s13063-020-04863-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711053/
https://www.ncbi.nlm.nih.gov/pubmed/33272319
http://dx.doi.org/10.1186/s13063-020-04863-5

Ejemplares similares